The ALS app supports the first genetic therapy for ALS with mutation in the SOD1 gene.

Since March 2022, two patients have been treated with the drug Tofersen at the ALS outpatient clinic of the Charité in Berlin. The documentation and monitoring of the course of treatment are

NF-L analysis results can now be viewed on the ALS app and in the APST web portal

More than 1,100 people with amyotrophic lateral sclerosis (ALS) are currently participating in the study “NF-L in ALS”, which is made possible by the Boris Canessa ALS Foundation

­Recognizing therapy effects in face and speech of ALS patients via the ALS app

APST is introducing digital speech and facial expression analysis via the ALS app in a model project. The analysis of speech and facial expressions in amyotrophic lateral sclerosis (ALS) is

ALS-App: provision of assistive technology devices and medicines despite pandemic measures

The ongoing pandemic situation and the measures associated with it also make outpatient care more difficult. The ALS app offers people with ALS the possibility to communicate online the need for

Further development of the ALS app: new features and improved software

Since February 2020, about 500 people with ALS use the ALS app. Now we have improved the software and added some new features. Since a few days the ALS-App 2.0 is available for free download in